---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286151833.md"
description: "Rigel Pharma shares are trading higher. The company announced an exclusive, global license agreement with Arvinas and Pfizer to develop, manufacture and commercialize VEPPANU, oral PROteolysis TArgeting Chimera."
datetime: "2026-05-12T19:44:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286151833.md)
  - [en](https://longbridge.com/en/news/286151833.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286151833.md)
---

# 

Rigel Pharma shares are trading higher. The company announced an exclusive, global license agreement with Arvinas and Pfizer to develop, manufacture and commercialize VEPPANU, oral PROteolysis TArgeting Chimera.

### Related Stocks

- [RIGL.US](https://longbridge.com/en/quote/RIGL.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ARVN.US](https://longbridge.com/en/quote/ARVN.US.md)

## Related News & Research

- [Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results | PFE Stock News](https://longbridge.com/en/news/287035698.md)
- [Pfizer Hemophilia Drug Win In Europe Adds Weight To Undervalued Thesis](https://longbridge.com/en/news/286344524.md)
- [Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference | RIGL Stock News](https://longbridge.com/en/news/286413210.md)
- [What Madrigal Pharmaceuticals (MDGL)'s Wider Q1 Losses and Rezdiffra Revenue Momentum Mean For Shareholders](https://longbridge.com/en/news/286674743.md)
- [Thrivent Financial for Lutherans Acquires 72,504 Shares of Pfizer Inc. $PFE](https://longbridge.com/en/news/286761926.md)